Suman Rao
The University of Sydney
1 paper in the Anchorcite directory, published in 2016, cited 10,276 times in total.
Research topics
- Cancer Immunotherapy and Biomarkers · 1 paper
- Lung Cancer Diagnosis and Treatment · 1 paper
- Lung Cancer Treatments and Mutations · 1 paper
Frequent co-authors
- Martin Reck · 1 paper
- Delvys Rodríguez‐Abreu · 1 paper
- Andrew George Robinson · 1 paper
- Rina Hui · 1 paper
- Tibor Csőszi · 1 paper
- Andrea Fülöp · 1 paper
- Maya Gottfried · 1 paper
- Nir Peled · 1 paper
Papers
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung CancerNew England Journal of Medicine · 2016 · 10,276 citations
BACKGROUND: Pembrolizumab is a humanized monoclonal antibody against programmed death 1 (PD-1) that has antitumor activity in advanced non-small-cell lung cancer (NSCLC), with increased activity in tumors that express programmed death ligand 1 (PD-L1). METHODS: In this open-label, phase 3…
Metadata from OpenAlex (CC0).